Hibernating substrate of ventricular tachycardia: a three-dimensional metabolic and electro-anatomic assessment

Ayman A Hussein1, Michelle Niekoop2, Vasken Dilsizian3

  • 1Section of Cardiac Pacing and Electrophysiology, Cleveland Clinic, Cleveland, OH, USA.

Insights

Hibernating myocardium, a state of reduced blood flow but preserved heart muscle function, exhibits abnormal electrical properties. This condition contributes to ventricular tachycardia (VT) and sudden cardiac death (SCD) risk in patients with ischemic heart disease.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Nuclear Cardiology

Background:

  • Hibernating myocardium (HM) is linked to sudden cardiac death (SCD).
  • The electrophysiological characteristics of HM and its role in SCD remain poorly understood.
  • Ventricular tachycardia (VT) is a significant concern in patients with ischemic heart disease.

Purpose of the Study:

  • To electrophysiologically characterize hibernating myocardium (HM) in patients experiencing ventricular tachycardia (VT).
  • To investigate the arrhythmogenic substrate associated with HM in ischemic heart disease.

Main Methods:

  • Endocardial voltage mapping combined with metabolic (18FDG-PET) and perfusion imaging (82Rb, 201Tl, or 99mTc) in 61 ischemic heart disease patients with VT.
  • Three-dimensional PET reconstructions integrated with voltage maps for hybrid metabolic-electro-anatomic assessment.
  • Identification and characterization of hibernating areas and their electrical properties.

Main Results:

  • Hibernating myocardium was identified in 13% (7/61) of patients with refractory VT.
  • Abnormal and heterogeneous bipolar (48.5%) and unipolar (78.3%) voltage recordings were observed within HM.
  • VT exit sites were located within HM in 3 of 6 assessed patients, indicating its role in arrhythmia generation.

Conclusions:

  • Hibernating myocardium exhibits significantly abnormal and heterogeneous electrical properties.
  • These electrical abnormalities in HM contribute to the substrate for ventricular tachycardia (VT).
  • HM may underlie the increased vulnerability to reentry and sudden cardiac death (SCD) in hypoperfused yet viable myocardium.
Abstract